We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

157 hedge funds and large institutions have $3.02B invested in Karuna Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

38% more capital invested

Capital invested by funds: $2.19B → $3.02B (+$835M)

10% more funds holding

Funds holding: 143 → 157 (+14)

11% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 55

73% less call options, than puts

Call options by funds: $4.46M | Put options by funds: $16.4M

Holders
157
Holders Change
+14
Holders Change %
+9.79%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
32
Increased
49
Reduced
55
Closed
17
Calls
$4.46M
Puts
$16.4M
Net Calls
-$11.9M
Net Calls Change
-$21.8M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$78.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.3M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$52.6M
4
CCM
CAAS Capital Management
New York
+$42.9M
5
MVP
Miller Value Partners
Florida
+$33M

Top Sellers

Rank Fund Capital Flow
1
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$19.8M
2
Norges Bank
Norges Bank
Norway
-$11.9M
3
MWNA
Marshall Wace North America
New York
-$9.31M
4
State Street
State Street
Massachusetts
-$7.65M
5
Millennium Management
Millennium Management
New York
-$6.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
51
Marshall Wace
United Kingdom
$5.51M +$5.2M +45,861 New
FAM
52
Fred Alger Management
New York
$5.08M +$4.79M +42,239 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$5.01M – – –
HNB
54
Huntington National Bank
Ohio
$4.59M – – –
Citigroup
55
Citigroup
New York
$4.57M +$3.2M +28,270 +289%
TD Asset Management
56
TD Asset Management
Ontario, Canada
$4.45M +$972K +8,581 +30%
First Manhattan
57
First Manhattan
New York
$3.86M -$3.93M -34,726 -52%
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$3.86M – – –
Man Group
59
Man Group
United Kingdom
$3.81M -$2.22M -19,575 -38%
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
$3.77M -$550K -4,853 -13%
Barclays
61
Barclays
United Kingdom
$3.64M -$1.18M -10,420 -26%
Bank of America
62
Bank of America
North Carolina
$3.62M +$645K +5,695 +23%
First Trust Advisors
63
First Trust Advisors
Illinois
$3.61M +$3.4M +29,997 New
PCM
64
Pinz Capital Management
New York
$3.46M +$3.26M +28,805 New
Rafferty Asset Management
65
Rafferty Asset Management
New York
$3.35M +$2.36M +20,859 +297%
Swiss National Bank
66
Swiss National Bank
Switzerland
$3.32M +$56.6K +500 +2%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$2.86M -$10.8K -95 -0.4%
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
$2.56M -$430K -3,800 -15%
Allianz Asset Management
69
Allianz Asset Management
Germany
$2.54M -$876K -7,730 -27%
LP
70
LMR Partners
United Kingdom
$2.4M +$2.27M +20,000 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$2.21M -$185K -1,633 -8%
Fidelity International
72
Fidelity International
Bermuda
$1.98M +$1.83M +16,196 +5,490%
CS
73
Credit Suisse
Switzerland
$1.93M -$737K -6,507 -29%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$1.68M -$125K -1,100 -7%
CPW
75
Catalyst Private Wealth
California
$1.56M – – –
1 2
3
4 5

KRTX Hedge Fund Activity: Q1 2021 in Review

157 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2021, worth a combined $3.02B — up 38% from $2.19B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new KRTX positions and 17 closed out — a net gain of 15 holders — while 49 added to existing stakes and 55 trimmed.

The largest buyer was Vanguard Group, adding an estimated $78.2M. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $19.8M.

  • 157 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2021, up from 143 in Q4 2020.
  • Funds reported $3.02B of Karuna Therapeutics, Inc. Common Stock stock for Q1 2021, up 38% quarter-over-quarter.
  • 32 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2021 and 17 closed out, a net change of +15 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q1 2021 was Vanguard Group, an estimated $78.2M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2021 was Pivotal bioVenture Partners Investment Advisor, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2021.